# Beam Therapeutics Inc.: Form 8-K, filed Oct 19, 2023

- Company: [Beam Therapeutics Inc.](/companies/beam.md) (CIK 1745999)
- Form: 8-K
- Filed: 2023-10-19
- Accepted by EDGAR: Oct 19, 2023, 08:50 ET
- Period: 2023-10-18
- Accession: 0001193125-23-258963
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1745999/000119312523258963/d517250d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1745999/000119312523258963/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1745999/000119312523258963/d517250d8k.htm

Filed Oct 19, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-258963. Last ingested by Listed: Nov 3, 2026, 08:58 ET. No prices; not investment advice.